Sponsored by: Fujifilm

Attendance

May 10, 2022
Latest in MRI
Caption: Representative images show emphysema and functional lung maps derived by CT and PREFUL-MRI: (A–C) CT-derived emphysema images, (D–F) perfusion maps, (G–I) regional ventilation maps, (J–L) flow-volume loop correlation metric maps, (M–O) ventilation/perfusion combined parameter maps. (A, D, G, J, M) Images in a 63-year-old male with normal spirometry: FEV1%pred = 89.0%, FEV1/FVC = 0.73; emphysema percentage = 0.2%, QDP = 7%, VDPRVent = 2%, VDPFVL-CM = 1%. (B, E, H, K, N) Images in a 65-year-old female with PRISm + RP: FEV1%pred = 71.2%, FVC %pred = 76.8%, FEV1/FVC = 0.76; emphysema percentage = 4.7%, QDP = 10%, VD-PRVent = 18%, VDPFVL-CM = 6%. (C, F, I, L, O) Images in a 57-year-old male with AO: FEV1%pred = 56.8%, FEV1/FVC = 0.52; emphysema = 11.1%, QDP = 31%, VDPRVent = 33%, VDPFVL-CM = 41%. AO = airflow obstruction, FEV1 = forced expiratory volume in 1 second, FVC = forced vital capacity, FVL-CM = flow-volume loop correlation metric, %pred = percent predicted, PREFUL = phase-resolved function lung, PRISm = preserved ratio impaired spirometry, QDP = perfusion defect percentage, RVent = regional ventilation, VDP = ventilation defect percentage.
MRI finds perfusion defects across a range of lung impairments
June 4, 2026
Preablation, postablation, and recurrence multiparametric MRI scans depict a 63-year-old man treated with transperineal focal laser ablation (TPLA) for localized prostate cancer. Clinical parameters included an initial prostate-specific antigen (PSA) level of 7.2 ng/mL, a Prostate Imaging Reporting and Data System (PI-RADS) grade 4 lesion (red circles) in the right apical peripheral zone, and a maximum tumor length of 5 mm. MRI-guided targeted biopsy confirmed a Gleason score 3+4 prostate cancer tumor. (A) Pre-ablation axial T2-weighted MRI scan and apparent diffusion coefficient (ADC) image shows the apical PI-RADS 4 lesion (circles). (B) Six-month post-ablation axial T2-weighted MRI scan and ADC image show cystic necrosis (arrows). There was no evidence of recurrence; the PSA level was 1.5 ng/mL. (C) One-year after ablation, the patient’s PSA level had increased to 4.3 ng/mL. Axial T2-weighted MRI scan and the ADC image shows a recurrent lesion (blue circles) in the right apical peripheral zone adjacent to the ablation scar. Targeted biopsy confirmed Gleason score 3+4 prostate cancer, which was classified as in-field recurrence of clinically significant prostate cancer and subsequently re-treated with TPLA. In summary, serial multiplanar MRI demonstrates treatment response after TPLA with post-ablation necrosis, followed by MRI-detected IFR confirmed with biopsy at 12-month follow-up. Multiparametric MRI was performed with a 3.0-T MRI scanner (Skyra; Siemens Healthineers) using T2-weighted, diffusion-weighted, and ADC sequences, with gadobenate dimeglumine contrast material administration (Bracco Diagnostics).
Image-guided focal laser ablation effective for prostate cancer
June 3, 2026
The Invisible Force Podcast Album Cover Auntminnie Jan 2026 Thumbnails
Podcast: Telltale signs your MRI safety standards are inadequate
June 2, 2026
Asco Thumb
ASCO: Surveillance MRI boosts breast cancer detection for Black women
May 30, 2026
Related Stories
2020 02 25 00 02 3958 Mri Breast Cancer 20200225002942
MRI
MRI can help guide women's treatment decisions for DCIS
2019 09 17 16 42 0082 Viewray Astro 2019
Image-Guided Surgery
ViewRay highlights presentation at ESTRO 2022
2022 05 10 17 09 1354 2022 05 10 Ismrm Mr Fingerprinting 400
Image Processing
Machine learning could enable 1-minute brain MRI scans
2022 05 10 17 27 4814 Ismrm Leiner Tim 400
MRI
Video from ISMRM 2022: Tim Leiner on his move to Mayo Clinic
More in MRI
MRI finds perfusion defects across a range of lung impairments
By Kate Madden Yee
Impaired lung function is associated with increased pulmonary perfusion defects detectable by a particular MRI technique.
June 4, 2026
Caption: Representative images show emphysema and functional lung maps derived by CT and PREFUL-MRI: (A–C) CT-derived emphysema images, (D–F) perfusion maps, (G–I) regional ventilation maps, (J–L) flow-volume loop correlation metric maps, (M–O) ventilation/perfusion combined parameter maps. (A, D, G, J, M) Images in a 63-year-old male with normal spirometry: FEV1%pred = 89.0%, FEV1/FVC = 0.73; emphysema percentage = 0.2%, QDP = 7%, VDPRVent = 2%, VDPFVL-CM = 1%. (B, E, H, K, N) Images in a 65-year-old female with PRISm + RP: FEV1%pred = 71.2%, FVC %pred = 76.8%, FEV1/FVC = 0.76; emphysema percentage = 4.7%, QDP = 10%, VD-PRVent = 18%, VDPFVL-CM = 6%. (C, F, I, L, O) Images in a 57-year-old male with AO: FEV1%pred = 56.8%, FEV1/FVC = 0.52; emphysema = 11.1%, QDP = 31%, VDPRVent = 33%, VDPFVL-CM = 41%. AO = airflow obstruction, FEV1 = forced expiratory volume in 1 second, FVC = forced vital capacity, FVL-CM = flow-volume loop correlation metric, %pred = percent predicted, PREFUL = phase-resolved function lung, PRISm = preserved ratio impaired spirometry, QDP = perfusion defect percentage, RVent = regional ventilation, VDP = ventilation defect percentage.
Image-guided focal laser ablation effective for prostate cancer
By Amerigo Allegretto
MRI-directed, ultrasound-guided TPLA may be a promising technique to treat prostate cancer while avoiding radical therapies.
June 3, 2026
Preablation, postablation, and recurrence multiparametric MRI scans depict a 63-year-old man treated with transperineal focal laser ablation (TPLA) for localized prostate cancer. Clinical parameters included an initial prostate-specific antigen (PSA) level of 7.2 ng/mL, a Prostate Imaging Reporting and Data System (PI-RADS) grade 4 lesion (red circles) in the right apical peripheral zone, and a maximum tumor length of 5 mm. MRI-guided targeted biopsy confirmed a Gleason score 3+4 prostate cancer tumor. (A) Pre-ablation axial T2-weighted MRI scan and apparent diffusion coefficient (ADC) image shows the apical PI-RADS 4 lesion (circles). (B) Six-month post-ablation axial T2-weighted MRI scan and ADC image show cystic necrosis (arrows). There was no evidence of recurrence; the PSA level was 1.5 ng/mL. (C) One-year after ablation, the patient’s PSA level had increased to 4.3 ng/mL. Axial T2-weighted MRI scan and the ADC image shows a recurrent lesion (blue circles) in the right apical peripheral zone adjacent to the ablation scar. Targeted biopsy confirmed Gleason score 3+4 prostate cancer, which was classified as in-field recurrence of clinically significant prostate cancer and subsequently re-treated with TPLA. In summary, serial multiplanar MRI demonstrates treatment response after TPLA with post-ablation necrosis, followed by MRI-detected IFR confirmed with biopsy at 12-month follow-up. Multiparametric MRI was performed with a 3.0-T MRI scanner (Skyra; Siemens Healthineers) using T2-weighted, diffusion-weighted, and ADC sequences, with gadobenate dimeglumine contrast material administration (Bracco Diagnostics).
Podcast: Telltale signs your MRI safety standards are inadequate
By Liz Carey
Check your MRI safety sense.
June 2, 2026
The Invisible Force Podcast Album Cover Auntminnie Jan 2026 Thumbnails
ASCO: Surveillance MRI boosts breast cancer detection for Black women
By Erik L. Ridley
Surveillance breast MRI could potentially reduce persistent racial disparities in breast cancer outcomes, according to a study presented at ASCO 2026.
May 30, 2026
Asco Thumb
Eye movement abnormalities flag brain health risk in ex-racing drivers
By Kate Madden Yee
A case series of 12 male retired professional motorsport drivers showed a high prevalence of mild neurological abnormalities.
May 29, 2026
Racecare Thumb
Philips brings Disney characters to pediatric MRI ambient experience
By AuntMinnie.com staff writers
The integration uses calming lighting, sound, and visual elements alongside Disney content.
May 28, 2026
Ambient Experience for MRI platform with Disney characters
GE HealthCare, NordicNeuroLab ink software distribution deal
By AuntMinnie.com staff writers
GE HealthCare will distribute NordicNeuroLab's nordicMEDiVA and nordicAktiva.
May 27, 2026
A Ipartnership
AI-powered MRI technique maps brain fluid flow tied to Alzheimer's
By Kate Madden Yee
A physics-informed AI framework reveals 3D fluid velocity pathways across the entire living brain using standard MRI data.
May 27, 2026
A 3D visualization shows the flow speed of fluid across the brain.
AI diagnostic aid helps novice MRI readers, but experts not so much
By Kate Madden Yee
The findings point to where AI decision support delivers the most clinical value.
May 26, 2026
Chat Gpt 3
American Board of Magnetic Resonance Safety rebrands with new name
By AuntMinnie.com staff writers
The ABMRS has changed its name to reflect the board's expanded global role in MR safety certification.
May 26, 2026
Mr Scanner 400 (2)
Hyperfine to join Russell 3000, Russell 2000 indexes in June
By AuntMinnie.com staff writers
Hyperfine is expected to join the Russell 3000 and Russell 2000 indexes in June.
May 26, 2026
Business Costs Rising Arrow Up 400
Multimodal brain health composites outperform standard AD biomarkers
By Kate Madden Yee
"Reproducible, multimodal composites can capture distinct yet complementary dimensions of brain health," researchers noted.
May 22, 2026
Brain Abstract
Page 1 of 645
Next Page